Cholesterol Management in the Era of PCSK9 Inhibitors.

about

Cholesterol Management in the Era of PCSK9 Inhibitors.

Item

http://www.wikidata.org/entity/Q38639580

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Cholesterol Management in the Era of PCSK9 Inhibitors.

@en

type

Item

label

Cholesterol Management in the Era of PCSK9 Inhibitors.

@en

prefLabel

Cholesterol Management in the Era of PCSK9 Inhibitors.

@en

P1476

Cholesterol Management in the Era of PCSK9 Inhibitors.

@en

P2093

Anna Svatikova

http://www.w3.org/2001/XMLSchema#string

Stephen L Kopecky

http://www.w3.org/2001/XMLSchema#string

P2860

Are PCSK9 Inhibitors the Next Breakthrough in the Cardiovascular Field?

Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

PCSK9 inhibitor access barriers-issues and recommendations: Improving the access process for patients, clinicians and payers.

Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.

National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary.

Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis.

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.

P2888

s11886-017-0891-5

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11886-017-0891-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091052847

http://www.w3.org/2001/XMLSchema#string

P698

28779284

http://www.w3.org/2001/XMLSchema#string

Cholesterol Management in the Era of PCSK9 Inhibitors.

about

Cholesterol Management in the Era of PCSK9 Inhibitors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698